Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa.

Benn Sartorius, C Cohen, T Chirwa, G Ntshoe, A Puren, K Hofman
Author Information
  1. Benn Sartorius: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, 27 St Andrews Road, Parktown, Johannesburg 2193, South Africa. benn.sartorius@wits.ac.za

Abstract

OBJECTIVE: To develop a model for identifying areas at high risk for sporadic measles outbreaks based on an analysis of factors associated with a national outbreak in South Africa between 2009 and 2011.
METHODS: Data on cases occurring before and during the national outbreak were obtained from the South African measles surveillance programme, and data on measles immunization and population size, from the District Health Information System. A Bayesian hierarchical Poisson model was used to investigate the association between the risk of measles in infants in a district and first-dose vaccination coverage, population density, background prevalence of human immunodeficiency virus (HIV) infection and expected failure of seroconversion. Model projections were used to identify emerging high-risk areas in 2012.
FINDINGS: A clear spatial pattern of high-risk areas was noted, with many interconnected (i.e. neighbouring) areas. An increased risk of measles outbreak was significantly associated with both the preceding build-up of a susceptible population and population density. The risk was also elevated when more than 20% of infants in a populous area had missed a first vaccine dose. The model was able to identify areas at high risk of experiencing a measles outbreak in 2012 and where additional preventive measures could be undertaken.
CONCLUSION: The South African measles outbreak was associated with the build-up of a susceptible population (owing to poor vaccine coverage), high prevalence of HIV infection and high population density. The predictive model developed could be applied to other settings susceptible to sporadic outbreaks of measles and other vaccine-preventable diseases.

References

  1. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78 [PMID: 21666158]
  2. MMWR Morb Mortal Wkly Rep. 1999 Jul 16;48(27):585-9 [PMID: 10428097]
  3. Epidemiol Rev. 1993;15(2):265-302 [PMID: 8174658]
  4. BMJ. 2010 May 18;340:c1626 [PMID: 20483946]
  5. Nature. 2008 Feb 7;451(7179):679-84 [PMID: 18256664]
  6. IARC Sci Publ. 1994;(128):1-302 [PMID: 7698823]
  7. J Infect Dis. 2001 Feb 15;183(4):532-8 [PMID: 11170977]
  8. Vaccine. 2012 Feb 21;30(9):1594-600 [PMID: 22230581]
  9. Lancet. 2004 Oct 2-8;364(9441):1236-43 [PMID: 15464184]
  10. Int J Epidemiol. 1991 Jun;20(2):508-14 [PMID: 1917257]
  11. S Afr Med J. 2011 Jul 25;101(8):519 [PMID: 21920140]
  12. J Infect Dis. 2011 Jul;204 Suppl 1:S260-9 [PMID: 21666171]
  13. J Epidemiol Community Health. 2007 Feb;61(2):165-71 [PMID: 17234878]
  14. MMWR Morb Mortal Wkly Rep. 2009 Dec 4;58(47):1321-6 [PMID: 19959985]
  15. Clin Infect Dis. 2007 Dec 1;45(11):1417-24 [PMID: 17990222]
  16. Pediatr Infect Dis J. 2012 May;31(5):474-80 [PMID: 22189531]
  17. Clin Infect Dis. 1999 Jul;29(1):106-12 [PMID: 10433572]
  18. Lancet. 2010 Nov 20;376(9754):1719-20 [PMID: 21093636]
  19. J Infect Dis. 2004 May 1;189 Suppl 1:S27-35 [PMID: 15106086]
  20. J Infect Dis. 1994 Nov;170 Suppl 1:S32-41 [PMID: 7930752]
  21. Wkly Epidemiol Rec. 2009 Dec 4;84(49):509-16 [PMID: 19960624]
  22. Int J Epidemiol. 2008 Apr;37(2):356-67 [PMID: 18234739]
  23. J Infect Dis. 2007 Aug 1;196(3):347-55 [PMID: 17597448]
  24. J Infect Dis. 2011 Jul;204 Suppl 1:S35-46 [PMID: 21666184]
  25. Environ Health Perspect. 2004 Jun;112(9):1016-25 [PMID: 15198922]
  26. Int J Epidemiol. 2005 Jun;34(3):556-64 [PMID: 15659463]
  27. Euro Surveill. 2009 Dec 17;14(50): [PMID: 20070932]
  28. Int J Health Geogr. 2011 Nov 18;10:61 [PMID: 22093084]
  29. Epidemiol Infect. 2010 Sep;138(9):1308-16 [PMID: 20096146]
  30. Int J Health Serv. 1997;27(4):767-90 [PMID: 9399118]
  31. Lancet. 1983 Apr 30;1(8331):972-5 [PMID: 6132278]
  32. J R Soc Interface. 2010 Nov 6;7(52):1537-44 [PMID: 20392713]
  33. Nat Rev Microbiol. 2006 Dec;4(12):900-8 [PMID: 17088933]
  34. Trop Med Int Health. 1998 Dec;3(12):962-74 [PMID: 9892281]

MeSH Term

Bayes Theorem
Comorbidity
Disease Outbreaks
Disease Susceptibility
HIV Infections
Humans
Incidence
Measles
Measles Vaccine
Models, Biological
Poisson Distribution
Population Density
Population Surveillance
Risk Assessment
South Africa
Spatial Analysis

Chemicals

Measles Vaccine

Word Cloud

Created with Highcharts 10.0.0measlesareaspopulationriskoutbreakmodelhighSouthsporadicassociateddensityhigh-risksusceptibleoutbreaksnationalAfricaAfricanusedinfantscoverageprevalenceHIVinfectionidentify2012build-upvaccineOBJECTIVE:developidentifyingbasedanalysisfactors20092011METHODS:DatacasesoccurringobtainedsurveillanceprogrammedataimmunizationsizeDistrictHealthInformationSystemBayesianhierarchicalPoissoninvestigateassociationdistrictfirst-dosevaccinationbackgroundhumanimmunodeficiencyvirusexpectedfailureseroconversionModelprojectionsemergingFINDINGS:clearspatialpatternnotedmanyinterconnectedieneighbouringincreasedsignificantlyprecedingalsoelevated20%populousareamissedfirstdoseableexperiencingadditionalpreventivemeasuresundertakenCONCLUSION:owingpoorpredictivedevelopedappliedsettingsvaccine-preventablediseasesIdentifyingoutbreaks:lessons

Similar Articles

Cited By